Pfizer to wait until after election to file COVID-19 vaccine in USPfizer said it will wait until after the US election to file its COVID-19 vaccine with the US Share XPfizer to wait until after election to file COVID-19 vaccine in UShttps://pharmaphorum.com/news/pfizer-to-wait-until-after-election-to-file-covid-19-vaccine-in-us/
Moderna broadens R&D scope with Vertex, Chiesi alliancesAll eyes may be on Moderna’s COVID-19 vaccine at the moment, but the US biotech hasn’t been idle Share XModerna broadens R&D scope with Vertex, Chiesi allianceshttps://pharmaphorum.com/news/moderna-broadens-rd-scope-with-vertex-chiesi-alliances/
AZ halts COVID-19 vaccine after safety scare, as UK faces ‘second wave’It’s a bleak day in the fight against COVID-19, after the UK banned social gatherings of more than Share XAZ halts COVID-19 vaccine after safety scare, as UK faces ‘second wave’https://pharmaphorum.com/news/az-halts-covid-19-vaccine-after-safety-scare-as-uk-faces-second-wave/
COVID-19 vaccine could be ready in time for US electionsHealth officials in the US have been told to prepare for a COVID-19 vaccine to be ready by Share XCOVID-19 vaccine could be ready in time for US electionshttps://pharmaphorum.com/news/covid-19-vaccine-could-be-ready-in-time-for-us-elections/
Moderna’s COVID vaccine works in older people, according to new dataModerna has said that its coronavirus vaccine stimulated an immune response in older people in phase 1 trials, Share XModerna’s COVID vaccine works in older people, according to new datahttps://pharmaphorum.com/news/moderna-covid-vaccine-works-in-older-people-according-to-new-data/
Anger at US deal for Moderna’s ‘taxpayer-funded’ COVID-19 vaccineThe US government has signed another big coronavirus vaccine supply deal, snapping up 100 million doses of Moderna’s Share XAnger at US deal for Moderna’s ‘taxpayer-funded’ COVID-19 vaccinehttps://pharmaphorum.com/news-market-access/anger-at-us-deal-for-modernas-taxpayer-funded-covid-19-vaccine/
Moderna gets further $472m as expanded phase 3 COVID-19 trial beginsA US government agency is to give a further $472 million to biotech Moderna, after it announced plans Share XModerna gets further $472m as expanded phase 3 COVID-19 trial beginshttps://pharmaphorum.com/news/moderna-gets-further-472m-as-expanded-phase-3-covid-19-trial-begins/
Controversy as pharma execs predict profits from COVID-19 vaccinesConcerns have emerged about access to some potential COVID-19 vaccines after pharma executives from three companies said they Share XControversy as pharma execs predict profits from COVID-19 vaccineshttps://pharmaphorum.com/news/controversy-as-pharma-execs-predict-profits-from-covid-19-vaccines/
Moderna’s $37B market cap is too high, despite COVID-19 vaccine; analystJP Morgan has downgraded its valuation of Moderna, saying its $37 billion market cap is way too high Share XModerna’s $37B market cap is too high, despite COVID-19 vaccine; analysthttps://pharmaphorum.com/news/modernas-37b-market-cap-is-too-high-despite-covid-19-vaccine-analyst/
